The Family Health Care Institute bulletin (one of King Hussein Foundation's institutes), on this Sunday, discusses nasal and ...

Females have a higher odds of chronic rhinosinusitis (CRS) without nasal polyps than men, according to a study published ...

The approval for the CRSwNP indication was based on data from the randomized, double-blind, placebo-controlled WAYPOINT trial.

Waking up with a stuffy nose is common and usually caused by allergies, nasal inflammation, post-nasal drip, sleep position ...

Approval based on WAYPOINT Phase III results demonstrating reduced nasal polyp severity and nasal congestion, near-elimination of the need for surgery and significantly reduced systematic ...

This document represents the first position statement produced by the British Society of Gastroenterology and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland, setting out ...

Amgen and AstraZeneca’s Tezspire (tezepelumab-ekko) gains FDA approval as an add-on maintenance therapy for patients aged 12 and older with inadequately controlled chronic rhinosinusitis with nasal ...

The FDA approved Amgen's and AstraZeneca's drug to treat chronic rhinosinusitis with nasal polyps, an inflammatory condition of the sinuses and nasal passages. The companies said the approval was ...

Abstract: Recently, many computer-aided diagnosis (CAD) methods have been proposed to help physicians automatically classify endoscopic images. However, most existing methods often result in poor ...

The final, formatted version of the article will be published soon. Abstract Background A gastric hamartomatous inverted polyp (GHIP) is an uncommon submucosal neoplasm that is histopathologically ...

CENTER VALLEY, Pa., Oct. 8, 2025 /PRNewswire/ — Olympus Corporation of the Americas, a global medical technology company committed to making people’s lives healthier, safer and more fulfilling, will ...